These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 10582709

  • 1. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ.
    Cancer Res; 1999 Nov 15; 59(22):5849-55. PubMed ID: 10582709
    [Abstract] [Full Text] [Related]

  • 2. Ability of breast cancer cell lines to stimulate bone resorbing activity of mature osteoclasts correlates with an anti-apoptotic effect mediated by macrophage colony stimulating factor.
    Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.
    Apoptosis; 2006 Nov 15; 11(11):1909-21. PubMed ID: 16927019
    [Abstract] [Full Text] [Related]

  • 3. Cellular mechanisms of bone resorption in breast carcinoma.
    Hunt NC, Fujikawa Y, Sabokbar A, Itonaga I, Harris A, Athanasou NA.
    Br J Cancer; 2001 Jul 06; 85(1):78-84. PubMed ID: 11437406
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.
    Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.
    J Surg Res; 2001 Sep 06; 100(1):18-24. PubMed ID: 11516200
    [Abstract] [Full Text] [Related]

  • 5. IL-6, LIF, and TNF-alpha regulation of GM-CSF inhibition of osteoclastogenesis in vitro.
    Gorny G, Shaw A, Oursler MJ.
    Exp Cell Res; 2004 Mar 10; 294(1):149-58. PubMed ID: 14980510
    [Abstract] [Full Text] [Related]

  • 6. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
    Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, Skinner RA, Swain F, Ramani V, Mohammad KS, Wessner LL, Martinez A, Guise TA, Chirgwin JM, Gaddy D, Suva LJ.
    Cancer Res; 2005 Dec 01; 65(23):11001-9. PubMed ID: 16322249
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts.
    Gallet M, Sévenet N, Dupont C, Brazier M, Kamel S.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):690-6. PubMed ID: 15178461
    [Abstract] [Full Text] [Related]

  • 8. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
    Sierra A, Price JE, García-Ramirez M, Méndez O, López L, Fabra A.
    Lab Invest; 1997 Oct 25; 77(4):357-68. PubMed ID: 9354770
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration.
    Zheng MH, Fan Y, Wysocki SJ, Lau AT, Robertson T, Beilharz M, Wood DJ, Papadimitriou JM.
    Am J Pathol; 1994 Nov 25; 145(5):1095-104. PubMed ID: 7977641
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteoclast synthesis and secretion and activation of latent transforming growth factor beta.
    Oursler MJ.
    J Bone Miner Res; 1994 Apr 25; 9(4):443-52. PubMed ID: 8030431
    [Abstract] [Full Text] [Related]

  • 16. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
    Hussein O, Tiedemann K, Komarova SV.
    Bone; 2011 Feb 25; 48(2):202-11. PubMed ID: 20849994
    [Abstract] [Full Text] [Related]

  • 17. Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment.
    Pilkington MF, Sims SM, Dixon SJ.
    J Bone Miner Res; 2001 Jul 25; 16(7):1237-47. PubMed ID: 11450699
    [Abstract] [Full Text] [Related]

  • 18. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
    El Hajj Dib I, Gallet M, Mentaverri R, Sévenet N, Brazier M, Kamel S.
    Eur J Pharmacol; 2006 Dec 03; 551(1-3):27-33. PubMed ID: 17049513
    [Abstract] [Full Text] [Related]

  • 19. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
    Kanatani M, Sugimoto T, Kano J, Kanzawa M, Chihara K.
    J Cell Physiol; 2003 Jul 03; 196(1):180-9. PubMed ID: 12767054
    [Abstract] [Full Text] [Related]

  • 20. Effects of human lymphocyte-conditioned medium on MG-63 human osteosarcoma cell function.
    Stock JL, Coderre JA, DeVito WJ, Baker S.
    Cytokine; 1998 Aug 03; 10(8):603-12. PubMed ID: 9722933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.